Related Experiment Video
Updated: May 8, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Abstract:
The cellular abl proto-oncogene encodes a protein-tyrosine kinase and is expressed in many cell types in two or three mRNA size species. Four types of mouse c-abl cDNAs have been cloned from 70Z/3 lymphoid cells that have different 5' sequences encoding predicted N-terminal regions of 20-45 amino acids. One of the four cDNAs has a predicted N-terminal sequence of met-gly-gln in common with the gag N terminus of v-abl. The 5' heterogeneity appears to be generated by alternative addition of 5' exons onto a common set of 3' exons. Alternative splicing occurs at the same site at which bcr sequences join to abl sequences in the Philadelphia chromosome translocation.
Insights
The cellular abl proto-oncogene, a protein-tyrosine kinase, shows varied mRNA sizes due to alternative splicing. This splicing occurs at the same site involved in the Philadelphia chromosome translocation.
Area of Science:
- Molecular Biology
- Oncogenesis
- Gene Expression
Background:
- The cellular abl proto-oncogene encodes a protein-tyrosine kinase.
- This gene is expressed in various cell types, typically as two or three distinct mRNA size variants.
Purpose of the Study:
- To investigate the structural diversity of mouse c-abl cDNAs.
- To understand the mechanisms generating heterogeneity in c-abl mRNA.
- To explore the relationship between c-abl splicing and oncogenic transformations.
Main Methods:
- Cloning of four types of mouse c-abl complementary DNAs (cDNAs) from 70Z/3 lymphoid cells.
- Analysis of the 5' sequences of the cloned cDNAs to determine predicted N-terminal amino acid sequences.
- Comparison of c-abl cDNA sequences with viral abl (v-abl) sequences.
Main Results:
- Four distinct mouse c-abl cDNAs were identified, each with unique 5' sequences encoding predicted N-terminal regions of 20-45 amino acids.
- One cDNA shared a met-gly-gln N-terminal sequence with the gag N terminus of v-abl.
- The observed 5' heterogeneity in c-abl cDNAs is attributed to the alternative addition of 5' exons to a common set of 3' exons.
- Alternative splicing was found to occur at the identical site where BCR sequences attach to ABL sequences in the Philadelphia chromosome translocation.
Conclusions:
- The cellular abl proto-oncogene exhibits significant structural diversity at the mRNA level.
- Alternative splicing is a key mechanism generating different forms of c-abl.
- The splicing site involved in c-abl heterogeneity is conserved in the context of oncogenic translocations like the Philadelphia chromosome.
Related Concept Videos
RNA Splicing
Pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

